Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.
The global Daptomycin market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Daptomycin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Daptomycin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Daptomycin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Daptomycin include Merck & Co., Pfizer, Teva, Mylan, Fresenius Kabi, Sagent Pharmaceuticals, Xellia, Hisun and HENGRUI PHARMA, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Daptomycin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Daptomycin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Daptomycin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Daptomycin sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Daptomycin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Daptomycin sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck & Co., Pfizer, Teva, Mylan, Fresenius Kabi, Sagent Pharmaceuticals, Xellia, Hisun and HENGRUI PHARMA, etc.
By Company
Merck & Co.
Pfizer
Teva
Mylan
Fresenius Kabi
Sagent Pharmaceuticals
Xellia
Hisun
HENGRUI PHARMA
Huadong Medicine
Segment by Type
350 mg Lyophilized Powder
500 mg Lyophilized Powder
Segment by Application
Adult
Pediatric Patients (1 to 17 years of age)
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Daptomycin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Daptomycin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Daptomycin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Daptomycin Product Introduction
1.2 Market by Type
1.2.1 Global Daptomycin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 350 mg Lyophilized Powder
1.2.3 500 mg Lyophilized Powder
1.3 Market by Application
1.3.1 Global Daptomycin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adult
1.3.3 Pediatric Patients (1 to 17 years of age)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Daptomycin Sales Estimates and Forecasts 2018-2029
2.2 Global Daptomycin Revenue by Region
2.2.1 Global Daptomycin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Daptomycin Revenue by Region (2018-2023)
2.2.3 Global Daptomycin Revenue by Region (2024-2029)
2.2.4 Global Daptomycin Revenue Market Share by Region (2018-2029)
2.3 Global Daptomycin Sales Estimates and Forecasts 2018-2029
2.4 Global Daptomycin Sales by Region
2.4.1 Global Daptomycin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Daptomycin Sales by Region (2018-2023)
2.4.3 Global Daptomycin Sales by Region (2024-2029)
2.4.4 Global Daptomycin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Daptomycin Sales by Manufacturers
3.1.1 Global Daptomycin Sales by Manufacturers (2018-2023)
3.1.2 Global Daptomycin Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Daptomycin in 2022
3.2 Global Daptomycin Revenue by Manufacturers
3.2.1 Global Daptomycin Revenue by Manufacturers (2018-2023)
3.2.2 Global Daptomycin Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Daptomycin Revenue in 2022
3.3 Global Key Players of Daptomycin, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Daptomycin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Daptomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Daptomycin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Daptomycin, Product Offered and Application
3.8 Global Key Manufacturers of Daptomycin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Daptomycin Sales by Type
4.1.1 Global Daptomycin Historical Sales by Type (2018-2023)
4.1.2 Global Daptomycin Forecasted Sales by Type (2024-2029)
4.1.3 Global Daptomycin Sales Market Share by Type (2018-2029)
4.2 Global Daptomycin Revenue by Type
4.2.1 Global Daptomycin Historical Revenue by Type (2018-2023)
4.2.2 Global Daptomycin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Daptomycin Revenue Market Share by Type (2018-2029)
4.3 Global Daptomycin Price by Type
4.3.1 Global Daptomycin Price by Type (2018-2023)
4.3.2 Global Daptomycin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Daptomycin Sales by Application
5.1.1 Global Daptomycin Historical Sales by Application (2018-2023)
5.1.2 Global Daptomycin Forecasted Sales by Application (2024-2029)
5.1.3 Global Daptomycin Sales Market Share by Application (2018-2029)
5.2 Global Daptomycin Revenue by Application
5.2.1 Global Daptomycin Historical Revenue by Application (2018-2023)
5.2.2 Global Daptomycin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Daptomycin Revenue Market Share by Application (2018-2029)
5.3 Global Daptomycin Price by Application
5.3.1 Global Daptomycin Price by Application (2018-2023)
5.3.2 Global Daptomycin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Daptomycin Market Size by Type
6.1.1 US & Canada Daptomycin Sales by Type (2018-2029)
6.1.2 US & Canada Daptomycin Revenue by Type (2018-2029)
6.2 US & Canada Daptomycin Market Size by Application
6.2.1 US & Canada Daptomycin Sales by Application (2018-2029)
6.2.2 US & Canada Daptomycin Revenue by Application (2018-2029)
6.3 US & Canada Daptomycin Market Size by Country
6.3.1 US & Canada Daptomycin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Daptomycin Sales by Country (2018-2029)
6.3.3 US & Canada Daptomycin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Daptomycin Market Size by Type
7.1.1 Europe Daptomycin Sales by Type (2018-2029)
7.1.2 Europe Daptomycin Revenue by Type (2018-2029)
7.2 Europe Daptomycin Market Size by Application
7.2.1 Europe Daptomycin Sales by Application (2018-2029)
7.2.2 Europe Daptomycin Revenue by Application (2018-2029)
7.3 Europe Daptomycin Market Size by Country
7.3.1 Europe Daptomycin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Daptomycin Sales by Country (2018-2029)
7.3.3 Europe Daptomycin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Daptomycin Market Size
8.1.1 China Daptomycin Sales (2018-2029)
8.1.2 China Daptomycin Revenue (2018-2029)
8.2 China Daptomycin Market Size by Application
8.2.1 China Daptomycin Sales by Application (2018-2029)
8.2.2 China Daptomycin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Daptomycin Market Size by Type
9.1.1 Asia Daptomycin Sales by Type (2018-2029)
9.1.2 Asia Daptomycin Revenue by Type (2018-2029)
9.2 Asia Daptomycin Market Size by Application
9.2.1 Asia Daptomycin Sales by Application (2018-2029)
9.2.2 Asia Daptomycin Revenue by Application (2018-2029)
9.3 Asia Daptomycin Sales by Region
9.3.1 Asia Daptomycin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Daptomycin Revenue by Region (2018-2029)
9.3.3 Asia Daptomycin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Daptomycin Market Size by Type
10.1.1 Middle East, Africa and Latin America Daptomycin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Daptomycin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Daptomycin Market Size by Application
10.2.1 Middle East, Africa and Latin America Daptomycin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Daptomycin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Daptomycin Sales by Country
10.3.1 Middle East, Africa and Latin America Daptomycin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Daptomycin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Daptomycin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Information
11.1.2 Merck & Co. Overview
11.1.3 Merck & Co. Daptomycin Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Merck & Co. Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck & Co. Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Daptomycin Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Pfizer Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Daptomycin Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Teva Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Daptomycin Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Mylan Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Fresenius Kabi
11.5.1 Fresenius Kabi Company Information
11.5.2 Fresenius Kabi Overview
11.5.3 Fresenius Kabi Daptomycin Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Fresenius Kabi Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Fresenius Kabi Recent Developments
11.6 Sagent Pharmaceuticals
11.6.1 Sagent Pharmaceuticals Company Information
11.6.2 Sagent Pharmaceuticals Overview
11.6.3 Sagent Pharmaceuticals Daptomycin Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Sagent Pharmaceuticals Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sagent Pharmaceuticals Recent Developments
11.7 Xellia
11.7.1 Xellia Company Information
11.7.2 Xellia Overview
11.7.3 Xellia Daptomycin Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Xellia Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Xellia Recent Developments
11.8 Hisun
11.8.1 Hisun Company Information
11.8.2 Hisun Overview
11.8.3 Hisun Daptomycin Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Hisun Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hisun Recent Developments
11.9 HENGRUI PHARMA
11.9.1 HENGRUI PHARMA Company Information
11.9.2 HENGRUI PHARMA Overview
11.9.3 HENGRUI PHARMA Daptomycin Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 HENGRUI PHARMA Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 HENGRUI PHARMA Recent Developments
11.10 Huadong Medicine
11.10.1 Huadong Medicine Company Information
11.10.2 Huadong Medicine Overview
11.10.3 Huadong Medicine Daptomycin Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Huadong Medicine Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Huadong Medicine Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Daptomycin Industry Chain Analysis
12.2 Daptomycin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Daptomycin Production Mode & Process
12.4 Daptomycin Sales and Marketing
12.4.1 Daptomycin Sales Channels
12.4.2 Daptomycin Distributors
12.5 Daptomycin Customers
13 Market Dynamics
13.1 Daptomycin Industry Trends
13.2 Daptomycin Market Drivers
13.3 Daptomycin Market Challenges
13.4 Daptomycin Market Restraints
14 Key Findings in The Global Daptomycin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Merck & Co.
Pfizer
Teva
Mylan
Fresenius Kabi
Sagent Pharmaceuticals
Xellia
Hisun
HENGRUI PHARMA
Huadong Medicine
听
听
*If Applicable.